Diasome Pharmaceuticals
Latest round
- Series B
Last raised
- Apr 2008
Total raised
- Undisclosed
Investors
- 2
About Diasome Pharmaceuticals
Diasome Pharmaceuticals, Inc.Founded in 2004 and headquartered in Cleveland, US, Diasome Pharmaceuticals, Inc. develops therapeutic technologies for metabolic health.Diasome Pharmaceuticals, Inc. provides innovative therapeutic solutions targeting metabolic disorders, particularly through its HDV technology. This technology aims to restore hepatocyte metabolism, addressing deficiencies related to conditions such as Type 1 Diabetes and Dyslipidemia.The revenue model of Diasome Pharmaceuticals, Inc. is built on partnerships and direct-to-consumer sales for its HDV technology.000 mn, the company plans to focus on expanding its product offerings and entering new geographic markets. In February 2024, they intend to launch upcoming products utilizing the latest technology advancements.
Who invested in Diasome Pharmaceuticals
2 investors across 1 round
See all investors in Diasome Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 15, 2008
Amount
Undisclosed
Investors
Questions about Diasome Pharmaceuticals
Who invested in Diasome Pharmaceuticals?
Diasome Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Diasome Pharmaceuticals raised?
Diasome Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Diasome Pharmaceuticals last raise money?
Diasome Pharmaceuticals's most recent round on record is a Series B, in Apr 2008.
What does Diasome Pharmaceuticals do?
Diasome Pharmaceuticals is a biotechnology company.
Where is Diasome Pharmaceuticals headquartered?
Diasome Pharmaceuticals is headquartered in Cleveland, US.
Which VCs invest in companies like Diasome Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Diasome Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Diasome Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.